Replies to post #196588 on NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Did you find anything on Luminus Holdings?

I couldn't find anything when I was digging around, so can't shed any light on Luminus..

(That's enough silly puns. Ed)

Longfellow95,

It was the first thing I thought about when I saw the name of the holding company (Luminus Holdings)

No, I could not find anything about it. Only this:

During the six months ended June 30, 2018, to complete a series of funding provided for in the Company’s joint development agreement dated September 3, 2016, the Company received $900,000 in cash from Luminus in exchange for 400,000 shares of the Company’s common stock. Luminus is owned by a significant shareholder of the Company.

Same date here:

Short-term debt – related party

On May 9, 2016, the Company received cash proceeds of $350,000 from the issuance of a convertible note to Novamune that matured on August 1, 2016, with a conversion rate of $1.50 per share, and an annual interest rate of 8%. On September 3, 2016, the maturity date was extended to March 3, 2017. During the six months ended June 30, 2017, the convertible note was converted into 233,345 shares of common stock of the Company. Novamune is owned by a significant shareholder of the Company.

https://www.nasdaq.com/markets/ipos/filing.ashx?filingid=12943861#INMUNE_EX106_HTM

I believe she still had a French company. It was mentioned on a patent somewhere if I am not mistaken. I thought it had a different name, but perhaps a change of name has happened in the meantime.

[Lykiri]

Longfellow95,

I found information about the “Entreprise Revimmune SAS à Paris”.
The information is in French but I think you can handle that….

Nom : Revlmmune SAS

Date de démarrage d'activité : 17/06/2014

Activité : recherche et développement biopharmaceutiques, incluant le développement de nouvelles molécules, la conduite d'essais cliniques et la commercialisation de ces nouveaux produits, médicaments ou molécules…

Président : Revlmmune, Inc., société du Delaware (Delaware Corporation) de droit américain, sise 4800 Montgomery Lane, Suite 800, Bethesda, Maryland 20814, Etats-Unis, authentification n o 1401874, représentée par Mme Linda Fairing Powers demeurant 9306 Kendale Road, Potomac, MD 20854 Etats-Unis.
Directeur Général : M. James Kelly Ganjei demeurant 10609 River Oaks Lane, Potomac, MD 20854 Etats-Unis.

http://entreprises.lefigaro.fr/revimmune-sas-75/entreprise-803071729